Experimental therapy CNP-104 shows positive one-year results in PBC study
The one-year results of a Phase 2a trial showed improvements across several measures associated with liver health and PBC progression.
The one-year results of a Phase 2a trial showed improvements across several measures associated with liver health and PBC progression.
Fenofibrate may offer sustained benefits for individuals living with PBC who do not fully respond to first-line therapy ursodeoxycholic acid.
While PBC is traditionally linked to symptoms like fatigue and itching, up to half of those affected develop osteoporosis.
According to a research review, broader autoantibody study could help with more accurate PBC diagnosis and lead to more personalized care.
This metaphor makes invisible symptoms visible and helps others understand that energy is finite.
Smoking cigarettes is not only linked to a higher risk of PBC, but more severe disease and worse outcomes in those living with it.
A disability doesn’t have to be visible or constant to impact how someone functions.
Researchers highlight progress in gut-targeted therapies for PBC
Most people with primary biliary cholangitis (PBC) can anticipate safe and successful pregnancies, new research finds.
You can’t fully be there for your kids if you’re not taking care of yourself.